The largest database of trusted experimental protocols

Electronic tissue disruptor

Manufactured by Qiagen

The electronic tissue disruptor is a lab equipment product designed to efficiently homogenize and disrupt various types of tissue samples. Its core function is to provide a controlled and consistent disruption of tissue samples for further processing and analysis.

Automatically generated - may contain errors

5 protocols using electronic tissue disruptor

1

GC-MS Analysis of Tumor Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gas chromatography-tandem mass spectrometry (GC-MS), subcutaneous tumor fragments weighing 5–15 mg were homogenized using an electronic tissue disruptor (Qiagen) in ice-cold 80:20 methanol:water (vol:vol) followed by with three freeze-thaw cycles in liquid nitrogen. The supernatant was collected after a 10 min centrifugation at 13,000xg at 4°C then lyophilized. To analyze isotope enrichment in the plasma, whole blood was chilled on ice then centrifuged for 1 minute at 13,000xg at 4°C to separate the plasma. Aliquots of 20–40 μl of plasma were added to 80:20 methanol:water to extract the metabolites, then lyophilized using a SpeedVac (Thermo), and re-suspended in 40 μl anhydrous pyridine. This solution was added to pre-prepared GC-MS autoinjector vials containing 80 μl N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) to derivatize polar metabolites. The samples were incubated at 70°C for 1 hour, then aliquots of 1 μl were injected for analysis. Samples were analyzed using either an Agilent 6890 or an Agilent 7890 gas chromatograph coupled to an Agilent 5973N or 5975C Mass Selective Detector, respectively. The observed distributions of mass isotopologues were corrected for natural abundance39 (link).
+ Open protocol
+ Expand
2

GC-MS Analysis of Tumor Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gas chromatography-tandem mass spectrometry (GC-MS), subcutaneous tumor fragments weighing 5–15 mg were homogenized using an electronic tissue disruptor (Qiagen) in ice-cold 80:20 methanol:water (vol:vol) followed by with three freeze-thaw cycles in liquid nitrogen. The supernatant was collected after a 10 min centrifugation at 13,000xg at 4°C then lyophilized. To analyze isotope enrichment in the plasma, whole blood was chilled on ice then centrifuged for 1 minute at 13,000xg at 4°C to separate the plasma. Aliquots of 20–40 μl of plasma were added to 80:20 methanol:water to extract the metabolites, then lyophilized using a SpeedVac (Thermo), and re-suspended in 40 μl anhydrous pyridine. This solution was added to pre-prepared GC-MS autoinjector vials containing 80 μl N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) to derivatize polar metabolites. The samples were incubated at 70°C for 1 hour, then aliquots of 1 μl were injected for analysis. Samples were analyzed using either an Agilent 6890 or an Agilent 7890 gas chromatograph coupled to an Agilent 5973N or 5975C Mass Selective Detector, respectively. The observed distributions of mass isotopologues were corrected for natural abundance39 (link).
+ Open protocol
+ Expand
3

Bioluminescence Imaging of Brain Metastases

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo metabolite analysis, metastatic lesions in mice brain were tracked by bioluminescence imaging using IVIS spectrum (Perkin Elmer) and specific metastatic lesions were surgically removed. The tumors were flash frozen in liquid nitrogen and stored at −80°C until further processing. Metastatic lesions weighing 30-50mg were homogenized using an electronic tissue disruptor (Qiagen) in 1ml chilled 80% methanol (LC-MS grade, Fisher Scientific) followed by three freeze-thaw cycles using liquid nitrogen and 37°C water bath. Supernatant was collected after a 10min centrifugation at 13,000g. The supernatant was collected and lyophilized using a Speed-Vac (Thermo) before running on LC-MS.
+ Open protocol
+ Expand
4

Extracting Metastatic Brain Tumor Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols

Timing: Approximately 1–2 h

Note: Metastatic lesions from several mice (n≅5) need to be analyzed to increase robustness and account for variability.

Based on the observed signal approximate the region of metastatic lesion in the brain. Resect BLI+ brain metastatic lesion using surgical blades and verify BLI signal in the resected metastatic lesion using IVIS imager. See troubleshooting 4.

CRITICAL: The isolated BLI positive tissue is likely to contain primarily tumor cells along with few brain resident cells. Minimize number of non-tumor cells in the collected tissue by precisely cutting only regions with high BLI signal. As controls pick BLI negative region within the brain and from the same region in mice with no brain metastasis.

Flash freeze collected tissues in liquid nitrogen and store at −80°C.

Homogenize 30–50 mg of metastatic lesion using an electronic tissue disruptor (Qiagen) in 1 mL chilled 80% methanol (LC-MS grade, Fisher Scientific). See troubleshooting 5.

Note: A minimum of 15 mg of tissue is required for further processing.

Subject the homogenized solution three freeze-thaw cycles using liquid nitrogen and 37°C water bath.

Centrifuge samples at 13,000 g for 10 min to precipitate macromolecules.

Collect supernatant carefully and lyophilize using Speed-Vac (Figure 3).

Schematic illustration showing metabolite extraction and analysis procedures

+ Open protocol
+ Expand
5

Metabolite Analysis of Brain Metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Timing: Approximately 60–70 min

For in vivo steady state metabolite analysis, once the average brain only or whole-body photon flux reached 106–107 p/sec/cm2/sr, mice were subjected to cardiac perfusion post D-luciferin injection and brain was isolated as described earlier.

Use ex vivo brain BLI signal to mark and surgically remove metastatic lesions.

Note: The isolated BLI positive tissue is likely to contain primarily tumor cells along with few non-tumor cells. Minimize number of non-tumor cells in the collected tissue by selecting BLI high signal regions. As controls for normalization pick BLI negative region within the brain and from the same region in mice with no brain metastasis.

Flash freeze tumors in liquid nitrogen and store at −80°C until further processing.

Sample preparation for Mass spectroscopy.

Homogenize metastatic lesions (30–50 mg) using an electronic tissue disruptor (Qiagen) in 1 mL chilled 80% methanol (LC-MS grade, Fisher Scientific).

Next, follow three freeze-thaw cycles by using liquid nitrogen and a 37°C water bath.

Centrifuge samples at 13,000 g for 10 min at 4°C.

Collect supernatant and lyophilize using a Speed-Vac.

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!